I. RESTATEMENT (Tables)

3 Months Ended

Dec. 31, 2016

I. Restatement Tables

Restatements

	December 31, 2016
Balance Sheet	PREVIOUSLY REPORTED		ADJUSTMENT			RESTATED
Total current assets	$	4,522,290	$	(415,003	)	$	4,107,287
Other assets		5,405,599		13,738,445			19,144,044
Total assets		9,927,889		13,323,442			23,251,331
Total liabilities		5,494,598		13,062,236			18,556,834
Stockholders' equity		4,433,291		261,206			4,694,497

	September 30, 2016
Balance Sheet	PREVIOUSLY REPORTED			ADJUSTMENT			RESTATED
Total current assets	$	5,887,646		$	(429,821	)	$	5,457,825
Other assets		5,710,601			13,717,699			19,428,300
Total assets		11,598,247			13,287,878			24,886,125
Total liabilities		12,554,315			13,011,023			25,565,338
Stockholders' deficit		(956,068	)		276,855			(679,213	)

	Three Months Ended December 31, 2016
Statement of Operations	PREVIOUSLY REPORTED			ADJUSTMENT			RESTATED
Research and development expenses	$	4,024,856		$	(476,599	)	$	3,548,257
Total operating expenses		5,431,865			(476,599	)		4,955,266
Operating loss		(5,414,607	)		476,599			(4,938,008	)
Interest income (expense), net		23,097			(492,248	)		(469,151	)
Net income		3,536,802			(15,649	)		3,521,153
Net income per share - basic	$	0.59					$	0.59
Net income per share - diluted	$	0.33					$	0.32

	Three Months Ended December 31, 2015
Statement of Operation	PREVIOUSLY REPORTED			ADJUSTMENT			RESTATED
Research and development expenses	$	5,169,507		$	(476,599	)	$	4,692,908
Total operating expenses		5,804,108			(476,599	)		5,327,509
Operating loss		(5,783,132	)		476,599			(5,306,533	)
Interest income (expense), net		1,985			(485,678	)		(483,693	)
Net income		2,341,813			(9,079	)		2,332,734
Net income per share - basic and diluted	$	0.53					$	0.53

	Accumulated Deficit
PREVIOUSLY REPORTED, SEPTEMBER 30, 2016	$	(285,667,977	)
ADJUSTMENT		276,855
RESTATED BALANCE, SEPTEMBER 30, 2016		(285,391,122	)
Net income - RESTATED		3,521,153
BALANCE, DECEMBER 31, 2016	$	(281,869,969	)